EUVIMEDEUVIMED entdecken
Crossref

NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs

Corinna Galli, Elena Bastia, Douglas A Hubatsch, Carol Toris iD, Shan Fan, Andrea Unser, Feryan Ahmed, Karen Y Torrejon, Francesco Impagnatiello

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2023.0102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Corinna Galli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nicox Research Institute, Bresso, Milan, Italy. Hauptthemen laut MEDLINE: Aqueous Humor, Intraocular Pressure, Schlemm's Canal, Trabecular Meshwork. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aqueous HumorIntraocular PressureSchlemm's CanalTrabecular MeshworkAnimalsDogsHumansMaleAntihypertensive AgentsBimatoprostOphthalmic SolutionsScleraUvea

Stichwörter der Autor:innen

aqueous humor dynamicsglaucomanitric oxideocular hypertension

Substanzen

Antihypertensive AgentsBimatoprostOphthalmic Solutions

Autor:innen und Institutionen

  • Nicox Research Institute, Bresso, Milan, Italy.
  • Nicox Ophthalmics, Durham, North Carolina, USA.
  • University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • The Ohio State University, Columbus, Ohio, USA.
  • Humonix Biosciences Inc., Albany, New York, USA.

ORCID-Profile: Carol Toris

Zitieren

APA

Galli, C., Bastia, E., Hubatsch, D. A., Toris, C., Fan, S., Unser, A., Ahmed, F., Torrejon, K. Y., & Impagnatiello, F. (2024). NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0102

Vancouver

Galli C, Bastia E, Hubatsch DA, Toris C, Fan S, Unser A, et al. NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2023.0102

BibTeX
@article{Galli2024,
  author = {Galli, Corinna and Bastia, Elena and Hubatsch, Douglas A and Toris, Carol and Fan, Shan and Unser, Andrea and Ahmed, Feryan and Torrejon, Karen Y and Impagnatiello, Francesco},
  title = {NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2023.0102}
}
Kostenlos starten →